Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2004-03-05
2009-10-06
Goddard, Laura B (Department: 1642)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C530S828000
Reexamination Certificate
active
07597894
ABSTRACT:
Provided are alternative reading frame (ARF) polypeptides as well as antigen presenting cell (APC) and dendritic cell (DC) based compositions and methods that employ alternative reading frame polypeptides. ARF polypeptides and ARF polypeptide-based compositions and methods are useful in the treatment of cancer and infectious disease.
REFERENCES:
patent: 5840839 (1998-11-01), Wang et al.
patent: 5976546 (1999-11-01), Laus et al.
patent: 6274378 (2001-08-01), Steinman et al.
patent: 1 001 022 (2000-05-01), None
patent: WO 97/29195 (1997-08-01), None
patent: WO 00/13699 (2000-03-01), None
patent: WO 01/00784 (2001-01-01), None
patent: WO 01/61356 (2001-08-01), None
patent: WO 01/74855 (2001-10-01), None
patent: WO 02/051994 (2002-07-01), None
Van Etten et al, 1991, 266:2313-2319.
sequence search result # 2, GenEmbl database from search 20070607—153205—us-10-794-514a-10.rge.
iHOP, p. 1 of 1.
Vidovic, 2004, 209:535-544.
iHOP, p. 1 only of 15 for “ACPP”.
Peshwa et al (The Prostate, 1998, 36:129-138).
Kono et al (Clinical Cancer Research, Nov. 2000, 8:3394-3400).
GenBank Accession No. M11730, humane HER-2, published Sep. 18, 1995, p. 1-3.
Rosenberg, Steven A., et al.; “Identification of BING-4 Cancer Antigen Translated from an alternative Open Reading Frame of a Gene in the Extended MHC Class II Region Usingi Lymphocytes from a Patient with a Durable Complete Regression Following Immunotherapy,”The Journal of Immunology. vol. 168, No. 5, pp. 2402-2407 (Mar. 1, 2002).
Yewdell, Jonathan W., et al.; “Defective Ribosomal Products (DRiPS); A Major Source of Antigenic Peptides for MHC Class I Molecules?,”The Journal of Immunology, vol. 157, No. 5, pp. 1823-1826 (Sep. 1, 1996).
Uenaka, Akiko, et al.; “Identification of a Unique Antigen Peptide pRL1 on BALB/c RL♂1 Leukemia Recognized by Cytotoxic T. Lymphocytes and Its Relation to theAktOncogene,”The Journal of Experimental Medicine, vol. 180, pp. 1599-1607 (Nov. 1994).
Malarkannan, Subramaniam, et al.; “Presentation of Out-of-Frame Peptide/HMc Class I Complexes by a Novel Translation Initiation Mechanism,”Immunity, vol. 10, No. 6, pp. 681-690 (Jun. 1999).
Bullock, Timothy N.J., et al.; “Initiation Codon Scanthrough Versus Termination Codon Readthrough Demonstrates Strong Potential for Major Histocompatibility Complex Class I—Restricted Cryptic Epitope Expression,”The Journal of Experimental Medicine, vol. 186, No. 7, pp. 1051-1057 (Oct. 6, 1997).
Nanbru, Cécile, et al.; “Alternative Translation of the Proto-oncogenec-mycby an Internal Ribosome Entry Site,”The Journal of Biological Chemistry, vol. 272, No. 51, pp. 32061-32066 (Dec. 19, 1997).
Elliott, Tim, et al.; “Recognition of Out-of-Frame Major Histocompatibility Complex Class I-Restricted Epitopes in vivo,”European Journal of Immunology, vol. 26, pp. 1175-1179 (1996).
Rom, Eran, et al.; “Polyamines Regulate the Expression of Ornithine Decarboxylase Antizyme in vitro by Inducing Ribosomal Frame-Shifting,”Proceedings of the National Academy of Sciences. vol. 91, pp. 3959-3963 (Apr. 1994).
Farabaugh, P. J., “Programmed Translational Frameshifting,”Annual Review Genet, vol. 30, pp. 507-528 (1996).
Shastri, Nilabh, et al.; “Major Histocompatibility Class I Molecules Can Present Cryptic Translation Products to T-cells,” The Journal of Biological Chemistry, vol. 270, No. 3, pp. 1088-1091 (Jan. 20, 1995).
Ronsin, Christophe, et al.; “A Non-AUG-Defined Alternative Open Reading Frame of the Intestinal Carboxyl Esterase mRNA Gererates an Epitope Recognized by Renal Cell Carcinoma-Reactive Tumor-Infiltrating Lymphocytes in Situ1,”The Journal of Immunology, vol. 163, No. 1, pp. 483-490 (Jul. 1, 1999).
Herr, Alan J., et al.: “Coupling of Open Reading Frames by Translational Bypassing,”Annual Review of Biochemistry, vol. 69, pp. 343-372 (2000).
Van Den Eynde, Benoit J., et al.; “A New Antigen Recognized by Cytolytic T Lymphocytes on a Human Kidney Tumor Results from Reverse Strand Transcription,”Journal of Experimental Medicine, vol. 190, No. 12, pp. 1793-1799 (Dec. 20, 1999).
Rock, Kenneth L., et al.; “Degradation of Cell Proteins and the Generation of MHC Class I-Presented Peptides,”Annual Review of Immunology, vol. 17, pp. 739-779 (1999).
Short, John D., “Translational Regulation of the JunD Messenger RNA,”The Journal of Biological Chemistry, vol. 277, No. 36, pp. 32697-32705 (Sep. 6, 2002).
Byrd, Marshall P., et al.; “Generation of Multiple Isoforms of Eukaryotic Translation Initiation Factor 4GI by Use of Alternate Translation Initiation Codons”Molecular and Cellular Biology, vol. 22, No. 13, pp. 4499-4511 (Jul. 2002).
Jopling, Catherine L., et al.; “L-Myc Protein Synthesis is Initiated by Internal Ribosome Entry,”RNA Journal, vol. 10. pp. 287-298 (2004).
Martin, Mickey M., “Translation of the Human Angiotensin II Type 1 Receptor mRNA is Mediated by a Highly Efficient Internal Ribosome Entry Site,”Molecular and Cellular Endocrinology, vol. 212, pp. 51-61 (2003).
Wang, Rong-Fu, et al.. “Utilization of an Alternative Open Reading Frame of a Normal Gene in Generating a Novel Human Cancer Antigen,”The Journal of Experimental Medicine, vol. 183, pp. 1131-1140 (Mar. 1996).
Moreau-Aubrey, Agnès, et al., “A Processed Pseudogene Codes for a New Antigen Recognized by a CD8+T Cell Clone on Melanoma,”The Journal of Experimental Medicine, vol. 191, No. 9, pp. 1617-1623 (May 1, 2000).
Probst-Kepper, Michael, et al., “An Alternative Open Reading Frame of the Human Macrophage Colony-Stimulating Factor Gene is Independently Translated and Codes for an Antigenic Peptide of 14 Amino Acids Recognized by Tumor-Infiltrating CD8 T Lymphocytes,”The Journal of Experimental Medicine, vol. 193, No. 10, pp. 1189-1198 (May 21, 2001).
Wulf, Gerburg M., et al.. “Role of Pin1 in the Regulation of p53 Stability and p21 Transactivation, and Cell Cycle Checkpoints in Response to DNA Damage,”The Journal of Biological Chemistry, vol. 277, No. 50, pp. 47976-47979 (Dec. 13. 2002).
Coulie, Pierre G., et al., “A New Gene Coding for a Differentiation Antigen Recognized by Autologous Cytolytic T Lymphocytes on HLA-A2 Melanomas,”The Journal of Experimental Medicine, vol. 180, pp. 35-42 (Jul. 1994).
Kawakami, Yutaka, et al., “Cloning of the Gene Coding for a Shared Human Melanoma Antigen Recognized by Autologous T Cells Infiltrating into Tumor,”Proceedings of the National Academy of Science, vol. 91, pp. 3515-3519 (Apr. 1994).
Baker, Alexander B.H., et al., “Melanocyte Lineage-Specific Antigen gp100 is Recognized by Melanoma-derived Tumor-Infiltrating Lymphocytes,”The Journal of Experimental Medicine, vol. 179, pp. 1005-1009 (Mar. 1994).
Beckmann, Matthias W., et al., “Detection of the HER-2
euProto-Oncogene Protein p185erbB2by a Novel Monoclonal Antibody (MAB-145 ww) in Breast Cancer Membranes from Oestrogen and Progesterone Receptor Assays,”The European Journal of Cancer, vol. 28. No. 2/3, pp. 322-326 (Feb./Mar. 1992).
Moll, Bernice, et al.. “Inverted Ratio of Inducer to Suppressor T-Lymphocyte Subsets in Drug Abusers with Opportunistic Infections,”Clinical Immunology and lmmunopathology, vol. 25, No. 3, pp. 417-423 (Dec. 1982).
Henttu, Pirkko, et al., “cDNA Coding for the Entire Human Prostate Specific Antigen Shows High Homologies to the Human Tissue Kallikrein Genes,”Biochemical and Biophysical Research Communications, vol. 160, No. 2, pp. 903-910 (Apr. 28, 1989).
Brichard, Vincent, et al., “The Tyrosinase Gene Codes for an Antigen Recognized by Autologous Cytolytic T Lymphocytes on HLA-A2 Melanomas,”The Journal of Experimental Medicine, vol. 178, pp. 489-495 (Aug. 1993).
Real, Francisco X., et al., Class I (Unique) Tumor Antigens of Human Melanoma,Journal of Experimental Medicine, vo
Diegel Michael
Graddis Thomas
Laus Reiner
Vidovic Damir
Dehlinger Peter J.
Dendreon Corporation
Goddard Laura B
King & Spalding LLP
Myers Fitch Susan J.
LandOfFree
Compositions and methods employing alternative reading frame... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods employing alternative reading frame..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods employing alternative reading frame... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4085467